Matches in Nanopublications for { ?s ?p "[A total of 168 individuals with acute myeloid leukemia (AML) (n = 137) and myelo dysplastic syndrome (n = 31) were investigated with CCA and LCA at mean intervals of 24 days (range: 11-116).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP213359.RAA1R-hoWo_8-HMADtqnwEpx0agbVua8CMdrOfpAqFywo130_assertion description "[A total of 168 individuals with acute myeloid leukemia (AML) (n = 137) and myelo dysplastic syndrome (n = 31) were investigated with CCA and LCA at mean intervals of 24 days (range: 11-116).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP213359.RAA1R-hoWo_8-HMADtqnwEpx0agbVua8CMdrOfpAqFywo130_provenance.
- NP511154.RAa677dshAd7OTLD7t9RZpTkwDIqqk-UZZNdHkJXNuK58130_assertion description "[A total of 168 individuals with acute myeloid leukemia (AML) (n = 137) and myelo dysplastic syndrome (n = 31) were investigated with CCA and LCA at mean intervals of 24 days (range: 11-116).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP511154.RAa677dshAd7OTLD7t9RZpTkwDIqqk-UZZNdHkJXNuK58130_provenance.
- NP928472.RASAXYoclFXD96PNf91hXp8Vx3lAvfDLtrU4a55VehZT8130_assertion description "[A total of 168 individuals with acute myeloid leukemia (AML) (n = 137) and myelo dysplastic syndrome (n = 31) were investigated with CCA and LCA at mean intervals of 24 days (range: 11-116).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP928472.RASAXYoclFXD96PNf91hXp8Vx3lAvfDLtrU4a55VehZT8130_provenance.
- NP808181.RAwXJ9IJRHVs8piATTiER_P-CcUhPLXLzR-eqlZV5y9uU130_assertion description "[A total of 168 individuals with acute myeloid leukemia (AML) (n = 137) and myelo dysplastic syndrome (n = 31) were investigated with CCA and LCA at mean intervals of 24 days (range: 11-116).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP808181.RAwXJ9IJRHVs8piATTiER_P-CcUhPLXLzR-eqlZV5y9uU130_provenance.